glp-1 agonist oral The challenge of developing alternatives to Ozempic, Wegovy and Mounjaro Innovent gets IND for oral

In 2024, we also saw unprecedented willingness by large numbers of patients to pay out of pocket, even in European markets, as public coverage of AOMs is still limited, at best, and more often non-existent

Indias pharma industry is strong

The science behind 24% weight loss results explained.

Loss of muscle mass and strength not only impairs mobility and quality of life, but also worsens insulin resistance, ...

The World Obesity Atlas 2024 reports over 1.5 billion projected cases by 2035, highlighting its growing threat among pediatric and adult populations globally

This receptor specifically interacts with GLP-1, a key hormone that plays an integral role in regulating blood glucose levels, lipid metabolism, and several other crucial biological functions